Read + Share
Si H, Kuziora M, Quinn KJ, Helman E, et al. A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line
Metastatic NSCLC Treatment: Results from the MYSTIC Study. Clin Cancer Res 2021;27:1631-1640.
PMID: 33355200
|
 |
|
Si H, Kuziora M, Quinn KJ, Helman E, et al. A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line
Metastatic NSCLC Treatment: Results from the MYSTIC Study. Clin Cancer Res 2021;27:1631-1640.
PMID: 33355200
|
|
|
|